Literature DB >> 21199649

A comparative study of the structural organization of spheres derived from the adult human subventricular zone and glioblastoma biopsies.

Einar Osland Vik-Mo1, Cecilie Sandberg, Mrinal Joel, Biljana Stangeland, Yasuhiro Watanabe, Alan Mackay-Sim, Morten Carstens Moe, Wayne Murrell, Iver Arne Langmoen.   

Abstract

Sphere forming assays have been useful to enrich for stem like cells in a range of tumors. The robustness of this system contrasts the difficulties in defining a stem cell population based on cell surface markers. We have undertaken a study to describe the cellular and organizational composition of tumorspheres, directly comparing these to neurospheres derived from the adult human subventricular zone (SVZ). Primary cell cultures from brain tumors were found to contain variable fractions of cells positive for tumor stem cell markers (CD133 (2-93%)/SSEA1 (3-15%)/CXCR4 (1-72%)). All cultures produced tumors upon xenografting. Tumorspheres contained a heterogeneous population of cells, but were structurally organized with stem cell markers present at the core of spheres, with markers of more mature glial progenitors and astrocytes at more peripheral location. Ultrastructural studies showed that tumorspheres contained a higher fraction of electron dense cells in the core than the periphery (36% and 19%, respectively). Neurospheres also contained a heterogeneous cell population, but did not have an organization similar to tumorspheres. Although tumorspheres clearly display irregular and neoplastic cells, they establish an organized structure with an outward gradient of differentiation. We suggest that this organization is central in maintaining the tumor stem cell pool.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21199649     DOI: 10.1016/j.yexcr.2010.12.022

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  12 in total

Review 1.  Neurospheres: a potential in vitro model for the study of central nervous system disorders.

Authors:  Laura da Silva Siqueira; Fernanda Majolo; Ana Paula Bornes da Silva; Jaderson Costa da Costa; Daniel Rodrigo Marinowic
Journal:  Mol Biol Rep       Date:  2021-03-25       Impact factor: 2.316

Review 2.  The importance of RHAMM in the normal brain and gliomas: physiological and pathological roles.

Authors:  Daniela Poodts; Yamila Molinari; Matías A Pibuel; Mariángeles Díaz; Sofía Amoia; Agustín Byrne; Silvia Hajos; Silvina Lompardía; Paula Franco
Journal:  Br J Cancer       Date:  2022-10-07       Impact factor: 9.075

3.  Glioblastoma multiforme: relationship to subventricular zone and recurrence.

Authors:  Margareth Kimura; Yeuh Lee; Ryan Miller; Mauricio Castillo
Journal:  Neuroradiol J       Date:  2013-11-07

4.  Synergistic drug combinations for a precision medicine approach to interstitial glioblastoma therapy.

Authors:  Elizabeth G Graham-Gurysh; Ananya B Murthy; Kathryn M Moore; Shawn D Hingtgen; Eric M Bachelder; Kristy M Ainslie
Journal:  J Control Release       Date:  2020-04-23       Impact factor: 9.776

5.  Transcriptional profiling of adult neural stem-like cells from the human brain.

Authors:  Cecilie Jonsgar Sandberg; Einar O Vik-Mo; Jinan Behnan; Eirik Helseth; Iver A Langmoen
Journal:  PLoS One       Date:  2014-12-16       Impact factor: 3.240

6.  Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.

Authors:  Biljana Stangeland; Awais A Mughal; Zanina Grieg; Cecilie Jonsgar Sandberg; Mrinal Joel; Ståle Nygård; Torstein Meling; Wayne Murrell; Einar O Vik Mo; Iver A Langmoen
Journal:  Oncotarget       Date:  2015-09-22

7.  Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma.

Authors:  Einar Osland Vik-Mo; Marta Nyakas; Birthe Viftrup Mikkelsen; Morten Carstens Moe; Paulina Due-Tønnesen; Else Marit Inderberg Suso; Stein Sæbøe-Larssen; Cecilie Sandberg; Jan E Brinchmann; Eirik Helseth; Anne-Marie Rasmussen; Knut Lote; Steinar Aamdal; Gustav Gaudernack; Gunnar Kvalheim; Iver A Langmoen
Journal:  Cancer Immunol Immunother       Date:  2013-07-02       Impact factor: 6.968

8.  Expansion of multipotent stem cells from the adult human brain.

Authors:  Wayne Murrell; Emily Palmero; John Bianco; Biljana Stangeland; Mrinal Joel; Linda Paulson; Bernd Thiede; Zanina Grieg; Ingunn Ramsnes; Håvard K Skjellegrind; Ståle Nygård; Petter Brandal; Cecilie Sandberg; Einar Vik-Mo; Sheryl Palmero; Iver A Langmoen
Journal:  PLoS One       Date:  2013-08-14       Impact factor: 3.240

9.  Novel anti-glioblastoma agents and therapeutic combinations identified from a collection of FDA approved drugs.

Authors:  Pengfei Jiang; Rajesh Mukthavaram; Rajesh Mukthavavam; Ying Chao; Ila Sri Bharati; Valentina Fogal; Sandra Pastorino; Xiuli Cong; Natsuko Nomura; Matt Gallagher; Taher Abbasi; Shireen Vali; Sandeep C Pingle; Milan Makale; Santosh Kesari
Journal:  J Transl Med       Date:  2014-01-17       Impact factor: 5.531

10.  Development of circadian oscillators in neurosphere cultures during adult neurogenesis.

Authors:  Astha Malik; Roudabeh J Jamasbi; Roman V Kondratov; Michael E Geusz
Journal:  PLoS One       Date:  2015-03-31       Impact factor: 3.752

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.